ABP 501 : ABP 501 : ABP 501

(Click on the Study ID to go to the Study Page and view the Lay Summary when it is available)
Study IDStudy Title

A Randomized, Double-Blind, Phase 3 Study of ABP 501 Efficacy and Safety Compared to Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis